Author

R. Hincapie

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

M. G. Finn· 2 shared A. Basak· 1 shared A. Gabba· 1 shared A. K. Shalek· 1 shared C. Zurla· 1 shared D. J. Irvine· 1 shared D. Vanover· 1 shared E. L. Blanchard· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

M. G. Finn

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintJan 18, 2024

Glycan-costumed virus-like particles promote type 1 anti-tumor immunity

V. Lensch, A. Gabba, R. Hincapie…·L. L. Kiessling

This study develops glycan-costumed virus-like particles that activate dendritic cells and induce type 1 anti-tumor immunity in a murine model.

DOI 10.1101/2024.01.18.575711

mouseproteomics

BioengineeringbioRxivPreprintApr 24, 2020

Treating Influenza and SARS-CoV-2 via mRNA-encoded Cas13a

E. L. Blanchard, D. Vanover, S. S. Bawage…·P. J. Santangelo

This study uses mRNA-encoded Cas13a to target and reduce influenza and SARS-CoV-2 RNA in vitro and in a mouse model, showing potential for therapeutic applications.

DOI 10.1101/2020.04.24.060418

mouseCRISPR screen